专利摘要:
An ergoline derivative of formula I: wherein R₁ represents a hydrogen atom or a methyl group; R₂ represents a hydrogen or halogen atom, a methyl, cyano or phenyl group or an alkylthio group having from 1 to 4 carbon atoms; R₃ represents a hydrocarbon group having from 1 to 4 carbon atoms; R₄ represents a hydrogen atom, a phenyl group or a hydrocarbon group having from1 to 4 carbon atoms; either (a) each of R₆ and R₇ represents a hydrogen atom or, taken together, R₆ and R₇ represent a valence bond and R₈ represents a hydrogen atom or a methoxy group, or (b) R₆ represents a hydrogen atom and R₇ and R₈ taken together represent a valence bond; W represents an oxygen atom or an imino group; A represents a group of the formula CHR₅, CH=CR₅ or CH₂CHR₅ wherein R₅ represents a hydrogen atom or an alkyl group having from 1 to 4 carbon atoms; X represents an oxygen or sulphur atom or an imino group; and n is 0, 1 or 2; or a pharmaceutically acceptable salt of such ergoline derivative; is an antihypertensive agent.
公开号:SU1634137A3
申请号:SU884355906
申请日:1988-06-20
公开日:1991-03-07
发明作者:Мантегани Серджио;Бромбилла Энцо;Темперилли Альдемио;Руггиери Даниэла;Сальвати Патрициа
申请人:Фармиталиа Карло Эрба С.Р.Л. (Фирма);
IPC主号:
专利说明:

Table 1
Way
o Connection




1- Ј (6-Methyl-D 9,10-ergolen8L-yl) methyl -2,4- (1H, ZN) -dihydropyrimidinedione
1- Ј (6-Methyl-y-9,10-ergolen8-yl) metshG -2, A- (1H, 3N) -dihydropyrimidinedione-N-tb-oxide
1 (6 Methyl-D-9,10-ergolsl-8ft-yl) methyl -2,4-imidazolin-dione
1 - (6-Methyl-D, -9,10-ergolen-8Y-yl) methyl -2,4-imidazolidinedione-N-6-oxide
Edouf, mg / kg p „s, (through the mouth)
0.046
0.050
0.190
0.198
权利要求:
Claims (1)
[1]
Claim
A method of obtaining ergoline derivatives of the general formula where Rή is C ^ -C ^ -alkyl;
A is a group —CH ^ CH — or —CHn = 0.1 or 2, characterized in that N-oxidation of the compound of the general formula is carried out wherein R 4 and A have the indicated meanings using organic peracid in a mixture of tetrahydrofuran and dimethylformamide at room temperature temperature for 2 hours 0
Table 1
Way o Compound Vdu about > mg / kg r.s. (through the mouth) Famous 1 ”£ (6-Methyl-D ~ 9,10-ergolen- (EP 0126968) ββ-yl) methyl] -2,4- (1Η, 3H) -di- 0,046 hydropyrimidinedione Proposed 1- ^ (b-Methyl-D-9,10-ergolen- as in example 1 8 $ -yl) methyl-2,4- (1Η, 3H) -dihydropyrimidinedione-N-tb-oxide 0,050 Famous(EP 0126968) 1 - [(6-Methyl-D-9,10-ergolsi-8] ¾-yl) methyl] -2,4-imidazolin- 0.190 DION Available 1- £ (6-Methyl-A-9,10-ergolen- as in example 2 8β-yl) methyl] -2,4-imidazole-dindione — Ν — 6-oxide 0.198
I
T l b l i c a 1
Compound Dose, mg / kg p.o. Smell of average blood pressure, no mercury, ea time "· 1 15 min 130 days | 1 h | 2 h 3 h 4 h 5 h 6 h | 8 h 1 ! 2h Famous her 9 e ♦ * (EP 0126968) Suggested 0.125 176.7 -22.9 -34.5 -33.9 -37.5-12.2 ** -21.0 -32.2 -35.5 -34.5 -42.7 -28.9 -25.5 -10.5 -7.3 -6.7 as in example 1 0.5 173.1 -45.1 -55.1 -58.5 -54.3 -44.3 -35.3 -27 Known (EP 0126968) 0.25 186.1 -26.8 -31, * -29.6 -37.5 -35.7 -31.4 -15.7 -14.6 ** “2.5 ** -4.5 ** -9,*"* Proposed in Example 2 1 179.1 -23.1 -27.5 -35.9 -3 *, 1 -35.0 -38.4 -36.5 -34.1 “27.8 -22.3 -14.2
* Average blood pressure before thymya (before treatment), 1 Minor
类似技术:
公开号 | 公开日 | 专利标题
RU2235725C2|2004-09-10|Derivatives of imidazopyridine, method for their preparing and intermediate compounds, pharmaceutical preparation based on thereof |, method for inhibition of gastric acid secretion and method for treatment of states associated with helicobacter pylori infection
SU1184443A3|1985-10-07|Method of producing thiazole derivatives |
US6316438B1|2001-11-13|Fused pyridopyridazine inhibitors of cGMP phosphodiesterase
DK141753B|1980-06-09|Analogous process for the preparation of azaspirodecan and undecanedione derivatives or acid addition salts thereof.
US4675321A|1987-06-23|Substituted pyrimidines useful as calcium channel blockers
TW200512184A|2005-04-01|10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
SU1349698A3|1987-10-30|Method of producing derivatives of pyrimidin-2-ons or salts thereof
FI67543C|1985-04-10|PHARMACEUTICAL FRAMEWORK FOR PHARMACOLOGICAL ACTIVITY 2- |) - 2-IMIDAZOLINE
IE55904B1|1991-02-14|Dihydropyridines
SK165498A3|1999-06-11|Benzimidazole compounds
SU1634137A3|1991-03-07|Method of producing ercoline derivatives
US5342960A|1994-08-30|Azomethines agonist compounds of the histamine H3 receptor for therapeutic use, pharmaceutical compositions acting as agonists of the said receptor and preparation process
HU198713B|1989-11-28|Process for producing ergolin derivatives and pharmaceutical compositions containing them as active components
US5523317A|1996-06-04|Method of reducing blood pressure
IL97753A|1995-01-24|4-Quinolyl and 4-isoquinolyl-dihydropyridines, their preparation and pharmaceutical compositions containing them
DK162886B|1991-12-23|1,4-DIHYDROPYRIDINE DERIVATIVES, PROCEDURES FOR PREPARING IT AND PHARMACEUTICAL PREPARATION CONTAINING THE COMPOUNDS
US4550114A|1985-10-29|Benzoquinolizines as α2 -adrenoceptor antagonists
US4954508A|1990-09-04|Pharmacologically active pyrazolopyridines
US4711901A|1987-12-08|1-6-naphthyridine derivatives useful in the treatment of blood vessel diseases
KR950001040B1|1995-02-08|Thiourea derivatives and anti-microbial agent and antiulcer agent containing the same
EP0257616A2|1988-03-02|Dihydropyridine derivates and pharmaceutical composition thereof
US4760081A|1988-07-26|1,6-naphthyridine derivatives useful for treating diseases of the blood vessels
US4824855A|1989-04-25|1,4-dihydropyridine derivatives
AU616057B2|1991-10-17|Use of basic nitro-phenyl-dihydropyridine amides as medicaments, new compounds and processes for their preparation via new intermediates
DK168764B1|1994-06-06|Tetracyclic indole derivatives and processes for preparing such derivatives and pharmaceutical compositions containing them
同族专利:
公开号 | 公开日
EP0296830B1|1993-02-03|
KR890000478A|1989-03-14|
NZ225099A|1990-09-26|
PT87790B|1992-10-30|
IL86795D0|1988-11-30|
IL86795A|1991-11-21|
PT87790A|1988-07-01|
US4859678A|1989-08-22|
DK341988A|1988-12-25|
HU197743B|1989-05-29|
FI882978A|1988-12-25|
IE63372B1|1995-04-19|
AU1818688A|1989-01-05|
GB8714767D0|1987-07-29|
KR960015965B1|1996-11-25|
HUT46913A|1988-12-28|
EP0296830A3|1989-12-06|
IE881862L|1988-12-24|
EP0296830A2|1988-12-28|
DE3878052T2|1993-05-19|
DK341988D0|1988-06-22|
FI88301B|1993-01-15|
JPS6422875A|1989-01-25|
DE3878052D1|1993-03-18|
ES2053736T3|1994-08-01|
AU609144B2|1991-04-26|
FI88301C|1993-04-26|
FI882978A0|1988-06-22|
ZA884451B|1989-05-30|
AT85336T|1993-02-15|
CA1293247C|1991-12-17|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题

GB2120242A|1982-04-30|1983-11-30|Erba Farmitalia|Ergoline derivatives|
DE3323119A1|1982-09-03|1984-03-08|Farmitalia Carlo Erba S.p.A., 20159 Milano|7-Cyano-ergolines|
PH21123A|1983-04-28|1987-07-27|Erba Farmitalia|Ergoline derivatives|
GB2173189B|1985-02-21|1988-04-27|Maruko Pharmaceutical Co|Ergoline derivatives and salts thereof and pharmaceutical compositions thereof|
DE3700825A1|1986-01-24|1987-07-30|Sandoz Ag|8 alpha -Acylaminoergolines, their preparation and use|
NL8700046A|1986-01-24|1987-08-17|Sandoz Ag|8 ALFA-ACYLAMINOERGOLINES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.|
GB8617907D0|1986-07-22|1986-08-28|Erba Farmitalia|Tetracyclic indole derivatives|DK0628042T3|1992-12-24|2001-11-12|Pharmacia & Upjohn Spa|Serotoninergic ergoline derivatives|
GB9407637D0|1994-04-18|1994-06-08|Erba Carlo Spa|Serotoninergic abeo-ergoline derivatives|
GB9603226D0|1996-02-15|1996-04-17|Pharmacia Spa|Heterocyclyl-ergoline derivatives|
US6060483A|1996-06-27|2000-05-09|Pharmacia & Upjohn S.P.A.|Antineurodegenerative ergoline derivatives|
法律状态:
优先权:
申请号 | 申请日 | 专利标题
GB878714767A|GB8714767D0|1987-06-24|1987-06-24|Egoline derivatives|
[返回顶部]